Skip to main content

Author: Gustaf Ingdam-Lindgren

Changes in M2Call’s Board of Directors

Copenhagen (Denmark), April 26, 2025.

We are delighted to welcome Per Christiansen, who will join M2Call’s Board of Directors and at the same time warmly say goodbye to Simon Goldschmidt.
Since the 1990s, Per Christiansen has held management positions in the health service over a 30-year period as hospital, psychiatry, health, and regional director in the Capital Region and North Denmark Region.
Per held the position as CEO of Rigshospitalet from 1 January 2015 to 31 December 2022. From 2009 to 2014, he was Regional Director of the North Denmark Region. From 2006 to 2009, he was Director of Hospitals and Psychiatry in the North Denmark Region. From 2001 to 2006, he was Director of Aalborg Hospital, and before that, he was Director of Psychiatry in the County of North Jutland from March 2000 to August 2001. Per holds an MSc in Political Science from Aarhus University.

Michael Lange, M2Call’s CEO, said: “Per Christiansen’s exceptional leadership skills and strategic experience in hospital and healthcare systems will bring a wealth of external expertise at a time when M2Call is preparing to enter our life-video-feed patient monitoring solution into the market. We are very confident that Per Christiansen will guide us to continuously build on our commitment to patient safety, activate healthcare personnel to demand greater patient safety, and to engage and share our vision with partners throughout the world.”

“At the same time, I want to express my sincere thanks to Simon Goldschmidt for the key role he played as a Board member over the last year. Simon has been a highly appreciated member of the Board, bringing a unique contribution and perspective of innovation to the company’s strategic discussions and always keeping patients’ well-being top of mind. We are very grateful for how he helped guide us through the transition from the development phase to market readiness.”

M2Call´s patient monitoring solution Migo achieves CE-Marking

Press                                                                                                         06.03.2025

Siemens Healthineers and M2Call                                                   

New AI camera solution from Siemens Healthineers gives nurses more time and supports patient safety in intensive care units

An advanced camera solution with artificial intelligence has achieved CE-marking and supports nurses’ work and patient safety at the Department of Anesthesia and Intensive Care at Rigshospitalet.

  • AI camera solution for intensive care units obtains CE mark.
  • The solution has been created through successful collaboration between Siemens Healthineers, the Department of Anesthesia and Intensive Treatment at Rigshospitalet and the MedTech company M2Call, which is part of the Zibra Group.
  • Great scaling potential in Denmark and internationally.

The intelligent camera solution, Migo, was developed to address the challenges posed by the increased use of single-patient rooms in new hospitals for healthcare staff in intensive care units. In these departments, the requirement to be constantly present with the patient creates challenges for the staff, who often need to briefly leave the room to carry out other relevant tasks. The camera solution, which has recently obtained CE-marking, enables nurses to monitor patients 24/7 through notifications and live video streaming, benefiting patients, relatives, and staff. With Migo, nurses can ‘carry their patient in their pocket,’ potentially freeing up resources in a busy clinical environment. The solution is already in operation at the Neurointensive Care Unit at Rigshospitalet.

Created in collaboration with nurses

The camera solution was developed in close collaboration with clinical staff from the Department of Anesthesia and Intensive Care at Rigshospitalet, Siemens Healthineers, and the MedTech company M2Call. The clinical staff have been actively involved throughout the development process, with their clinical needs and patient safety as focal points. During development, user tests were continuously conducted, and feedback from healthcare staff played a decisive role in optimizing the solution’s functionality and user experience.

“The collaboration with Siemens Healthineers and Rigshospitalet has been essential for the development of Migo, as their insights into user needs, patient safety, and market dynamics have been invaluable in our work to develop the technology. The strong collaboration has also been crucial to our success in developing a product that has obtained the CE mark in just four years and can now benefit both healthcare staff and patients in intensive care units,” says Michael Lange, CEO of M2Call.

Great growth potential at home and abroad

Siemens Healthineers is the exclusive global distributor for intensive care units and is ready to roll out the solution.

“Initially, we are focusing on the Danish market before expanding to the Nordics. This product is unique and a natural extension of our portfolio, where we aim to innovate — including solutions that may not traditionally fit within our core modalities, such as scanners, beam guns, and laboratory equipment. We see Denmark as a key market for developing new technology that addresses specific challenges in the healthcare sector, not only in Denmark but globally” says Ole Nygaard, Head of Digital, Nordic and Baltic countries at Siemens Healthineers.

The patient in the pocket

The AI technology in Migo detects clinically significant, potentially critical movements and sends a notification to staff via an app on a smart device, indicating the detected movement and allowing real-time video access to the patient. This ensures that the patient remains “in the pocket” of healthcare professionals. Health technology and innovation are central to the future of healthcare, and as a result, there are high expectations for the solution’s scalability across Denmark and internationally.

………………………………………………….

Product (Migo)
Migo is an intelligent camera solution for 24/7 patient monitoring. The camera utilizes artificial intelligence to detect specific potentially critical movements and can send notifications and real-time video of the patient to the nurse via an app on a smart device.

Press Contact:

………………………….

M2Call

M2Call is a MedTech company founded in 2021 and is a part of Zibra Group. M2Call is located in the MindFuture Tech Hub in Taastrup, Denmark. At M2Call we are committed to deliver people-oriented innovation to healthcare for both patients and healthcare personnel. We do this by collaborating closely with doctors, nurses, and other healthcare professionals to ensure that the solutions we develop always fit the purpose it was made for.

Siemens Healthineers

Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2024, which ended on September 30, 2024, Siemens Healthineers had approximately 72,000 employees worldwide and generated revenue of around €22.4 billion. Further information is available at www.siemens-healthineers.com.